Fair Value Measurements | Fair Value Measurements Financial Assets The following tables provide the financial assets measured at fair value on a recurring basis: Amortized Gross Gross Fair Value Hierarchy as of Aggregate Level 1 Level 2 Level 3 Financial Assets: (In thousands) Cash and cash equivalents: Money market funds $ 272,248 $ — $ — $ 272,248 $ — $ — $ 272,248 Reverse repurchase agreements 200,000 — — — 200,000 — 200,000 Commercial paper 24,900 — — — 24,900 — 24,900 Total included in cash and cash equivalents 497,148 — — 272,248 224,900 — 497,148 Marketable securities: U.S. Treasury securities 410,933 2 (9,694) 401,241 — — 401,241 Non-U.S. government securities 181,628 — (4,983) 176,645 — — 176,645 Corporate debt securities and commercial paper 3,095,397 180 (67,173) 11,000 3,017,404 — 3,028,404 Total marketable securities 3,687,958 182 (81,850) 588,886 3,017,404 — 3,606,290 Total financial assets $ 4,185,106 $ 182 $ (81,850) $ 861,134 $ 3,242,304 $ — $ 4,103,438 Amortized Gross Gross Fair Value Hierarchy as of Aggregate Level 1 Level 2 Level 3 Financial Assets: (In thousands) Cash and cash equivalents: Money market funds $ 786,548 $ — $ — $ 786,548 $ — $ — $ 786,548 Commercial paper 46,076 — — — 46,076 — 46,076 Total included in cash and cash equivalents 832,624 — — 786,548 46,076 — 832,624 Marketable securities: U.S. Treasury securities 375,305 6 (2,561) 372,750 — — 372,750 Non-U.S. government securities 221,641 — (1,355) 220,286 — — 220,286 Corporate debt securities and commercial paper 3,300,326 960 (15,892) 31,000 3,254,394 — 3,285,394 Total marketable securities 3,897,272 966 (19,808) 624,036 3,254,394 — 3,878,430 Total financial assets $ 4,729,896 $ 966 $ (19,808) $ 1,410,584 $ 3,300,470 $ — $ 4,711,054 The Company's primary objective when investing excess cash is preservation of capital, hence the Company's marketable securities primarily consist of U.S. Treasury Securities, non-U.S government securities, high credit quality corporate debt securities and commercial paper. As the Company views its marketable securities as available to support current operations, it has classified all available for sale securities as short-term. As of March 31, 2022 and 2021, for fixed income securities that were in unrealized loss positions, the Company has determined that (i) it does not have the intent to sell any of these investments, and (ii) it is not more likely than not that it will be required to sell any of these investments before recovery of the entire amortized cost basis. In addition, as of March 31, 2022 and 2021, the Company anticipates that it will recover the entire amortized cost basis of such fixed income securities before maturity. Interest earned on marketable securities was $15.6 million and $3.9 million in the three months ended March 31, 2022 and 2021, respectively. The interest is recorded as other expenses, net, in the accompanying condensed consolidated statements of operations. The following table summarizes the contractual maturities of marketable securities: As of March 31, 2022 As of December 31, 2021 Amortized Aggregate Amortized Aggregate Financial Assets: (In thousands) Less than one year $ 1,066,875 $ 1,061,276 $ 1,084,751 $ 1,085,006 One to three years 2,621,083 2,545,014 2,812,521 2,793,424 Total $ 3,687,958 $ 3,606,290 $ 3,897,272 $ 3,878,430 Strategic Investments As of March 31, 2022 and December 31, 2021, the Company held strategic investments with a carrying value of $69.3 million and $68.3 million, respectively, recorded as other long-term assets in the accompanying condensed consolidated balance sheets. The carrying value of these securities is determined under the measurement alternative on a non-recurring basis and adjusted for observable changes in fair value. There were no impairments or other adjustments recorded in the three months ended March 31, 2022 and 2021 related to these securities. Financial Liabilities The Company’s financial liabilities that are measured at fair value on a recurring basis consist of foreign currency derivative liabilities and are classified as Level 2 financial instruments in the fair value hierarchy. As of March 31, 2022 and December 31, 2021, the aggregate fair value of these instruments and the associated gross unrealized losses were not significant. |